Next Article in Journal
Omega-3 Fatty Acids in Modern Parenteral Nutrition: A Review of the Current Evidence
Previous Article in Journal
The Application of Genetic Risk Scores in Age-Related Macular Degeneration: A Review
Open AccessReview

Acute Myeloid Leukemia: A Concise Review

Medical Oncology/Hematology, Department of Internal Medicine, Starling-Loving Hall, Room M365, 320 W. 10th Ave., Columbus, OH 43210, USA
Division of Hematology, Department of Internal Medicine, 460 W 12th Ave, Columbus, OH 43210, USA
Author to whom correspondence should be addressed.
Academic Editor: Jeffrey E. Rubnitz
J. Clin. Med. 2016, 5(3), 33;
Received: 11 December 2015 / Revised: 1 February 2016 / Accepted: 29 February 2016 / Published: 5 March 2016
Acute myeloid leukemia (AML) is a heterogeneous clonal disorder characterized by immature myeloid cell proliferation and bone marrow failure. Cytogenetics and mutation testing remain a critical prognostic tool for post induction treatment. Despite rapid advances in the field including new drug targets and increased understanding of the biology, AML treatment remains unchanged for the past three decades with the majority of patients eventually relapsing and dying of the disease. Allogenic transplant remains the best chance for cure for patients with intermediate or high risk disease. In this review, we discuss the landmark genetic studies that have improved outcome prediction and novel therapies. View Full-Text
Keywords: AML; leukemia; review AML; leukemia; review
MDPI and ACS Style

Saultz, J.N.; Garzon, R. Acute Myeloid Leukemia: A Concise Review. J. Clin. Med. 2016, 5, 33.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop